老年痴呆症非药理干预措施的有效性:一项随机对照试验
Huong Thu Vu1,2, Hung Trong Nguyen2,3, Anh Trung Nguyen1,2
1Department of Geriatrics, Hanoi Medical University, Hanoi 100000, Vietnam.
Geriatrics (Basel, Switzerland)
|April 26, 2024
概括
这项研究表明,多因素非药物干预显著改善痴呆症患者的心理健康和日常功能. 这些干预措施为昂贵且容易产生副作用的药物提供了有希望的替代品.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 痴呆症缺乏治愈方法,现有的药物提供有限的益处和显著的副作用.
- 药物治疗痴呆症的高成本和不良影响迫切需要探索非药物替代方案.
- 多因素非药物干预越来越多地被认为具有管理痴呆症症状和改善患者福祉的潜力.
研究的目的:
- 评估对痴呆患者多因素非药物干预计划的有效性.
- 评估干预对抑郁症,睡眠障碍,日常功能和生活质量的影响.
- 提供支持非药理学方法作为痴呆症可行的管理策略的证据.
主要方法:
- 从2021年7月到2022年12月,在海东进行了一项随机对照试验,对88名痴呆症患者 (非常轻度至中度严重) 进行.
- 参与者被分为干预组 (n=44) 和对照组 (n=44).
- 干预组接受了一项多因素计划,包括体育活动,认知训练,教育讲座和社会建模.
主要成果:
- 干预组的抑郁症得分显著降低 (GDS 15: 4.8 到 2.9) 和睡眠障碍 (PSQI: 10.2 到 5.6).
- 通过ADL和IADL得分来衡量日常功能,在干预组改善 (ADL: +1.02,IADL: +1.23) 在对照组下降.
- 干预组的生活质量 (EQ-5D-5L) 改善 (+0.17),对照组下降 (-0.20).
结论:
- 多因素非药物干预有效改善心理健康,包括减少痴呆患者的抑郁和睡眠障碍.
- 这些干预措施提高了痴呆症患者的日常功能和整体生活质量.
- 该研究强调了将体育活动,认知训练,教育和社会参与作为痴呆症管理治疗策略的价值.
相关概念视频
01:22Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
121
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
121
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:30Cognitive Development During Adulthood
94
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
94
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43